Key result
NPR3 rs2270915 G/G genotype is linked to ~94% higher odds of diastolic dysfunction.
Why the study?
Whether the NPR3 rs2270915 SNP (N521D) is associated with alterations in natriuretic peptide levels and cardiac structure and function was unknown.
Is the NPR3 rs2270915 SNP associated with diastolic dysfunction and altered natriuretic peptide levels in the general community?
Cross-Sectional (n=1,931)
No
Is the NPR3 rs2270915 SNP associated with diastolic dysfunction and altered natriuretic peptide levels in the general community?
A functional genetic variant in NPR3 (rs2270915) is independently associated with diastolic dysfunction without affecting circulating natriuretic peptide levels.
Answers are grounded in this paper and cite their sources.
NPR3 rs2270915 variant shows hypothesis-generating links to NPs and myocardial parameters; larger studies needed before clinical relevance.
OBJECTIVES: To evaluate the impact of a functional genetic variant in the natriuretic peptide clearance receptor, NPR3, on circulating natriuretic peptides (NPs) and myocardial structure and function in the general community. BACKGROUND: NPR3 plays an important role in the clearance of NPs and through direct signaling mechanisms modulates smooth muscle cell function and cardiac fibroblast proliferation. A NPR3 nonsynonymous single nucleotide polymorphism (SNP) rs2270915, resulting in a N521D substitution in the intracellular catalytic domain that interacts with Gi could affect receptor function. Whether this SNP is associated with alterations in NPs levels and altered cardiac structure and function is unknown. METHODS: DNA samples of 1931 randomly selected residents of Olmsted County, Minnesota were genotyped. Plasma NT-proANP1-98, ANP1-28, proBNP1-108, NT-proBNP1-76, BNP1-32 and BNP3-32 levels were measured. All subjects underwent comprehensive echocardiography. RESULTS: Genotype frequencies for rs2270915 were as follows: (A/A 60%, A/G 36%, G/G 4%). All analyses performed were for homozygotes G/G versus wild type A/A plus the heterozygotes A/G. Diastolic dysfunction was significantly more common (p = 0.007) in the homozygotes G/G (43%) than the A/A+A/G (28%) group. Multivariate regression adjusted for age, sex, body mass index and hypertension demonstrated rs2270915 to be independently associated with diastolic dysfunction (odds ratio 1.94, p = 0.03). There was no significant difference in NPs levels between the 2 groups suggesting that the clearance function of the receptor was not affected. CONCLUSIONS: A nonsynonymous NPR3 SNP is independently associated with diastolic dysfunction and this association does not appear to be related to alterations in circulating levels of natriuretic peptides.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2014) conducted a cross-sectional in Diastolic dysfunction (n=1,931). NPR3 rs2270915 G/G genotype vs. NPR3 rs2270915 A/A or A/G genotypes was evaluated on Diastolic dysfunction (OR 1.94, 95% CI 1.07-3.51, p=0.03). The NPR3 rs2270915 G/G homozygous genotype was independently associated with a higher prevalence of diastolic dysfunction compared to A/A and A/G genotypes.
Synapse has enriched 10 related papers. Consider them for comparative context: